FY25 consensus $582.06M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- Buy Rating for TransMedics Group Amid Strong Q2 Prospects and Seasonal Challenges
- Cautious Optimism for TransMedics Group Amid Strong Growth Indicators
- TransMedics Group: Strong Market Position and Ethical Practices Justify Buy Rating Amid Controversies
- TransMedics price target raised to $142 from $129 at Canaccord
- Strong Financial Outlook: TransMedics Group’s Surpassing Sales and EPS Forecasts